Company: BOLT
Filing Date: 2025-04-16
Form Type: PRE 14A
Source: 0000950170-25-054405
Chunk: 32

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-04-16
Form: PRE 14A
Chunk 32
---
 described below:

|                    |     | Years Ended December 31, |      2024 |     |   |    2023 |
|:-------------------|:----|:-------------------------|----------:|:----|:--|--------:|
| Audit fees(1)      |     | $                        |   990,000 |     | $ | 895,000 |
| Audit-related fees |     |                          |         — |     |   |       — |
| Tax fees(2)        |     |                          |    28,960 |     |   |  41,200 |
| All other fees(3)  |     |                          |     2,000 |     |   |   2,000 |
| Total fees         |     | $                        | 1,020,960 |     | $ | 938,200 |

(1) Audit fees consist of fees professional services rendered for the annual audit of our financial statements, the review of our interim financial statements, and comfort letters, consents and assistance with and review of documents filed with the SEC. (2) Tax fees consists of fees for services provided for tax consultation services. (3) Consist of fees for products and services other than the services described above. All other fees for the years ended December 31, 2024 and 2023 were related to annual subscription to accounting literature and tools. Pre-Approval Policies and Procedures The audit committee is required to pre-approve the audit and non-audit services performed by our independent registered public accounting firm in order to assure that the provision of such services does not impair the auditor’s independence. Any proposed services exceeding pre-approved cost levels require specific pre-approval by the audit committee. The audit committee at least annually reviews and provides general pre-approval for the services that may be provided by the independent registered public accounting firm; the term of the general pre-approval is 12 months from the date of approval, unless the audit committee specifically provides for a different period. If the audit committee has not provided general pre-approval, then the type of service requires specific pre-approval by the audit committee. The audit committee may delegate pre-approval authority to its chairperson. The chairperson must report any pre-approval decisions to the full audit committee at its next scheduled meeting. The annual audit services, engagement terms, and fees are subject to the specific pre-approval of the audit committee. All services performed and related fees billed by Pricewaterhouse